MBRX: Moleculin Biotech, Inc. 2020-10-01 07:30:00 Moleculin Announces Positive Interim Results in Pediatric Brain Tumor Phase 1 Clinical Trial at Emory University
IMMU: Immunomedics 2020-09-19 11:00:10 Immunomedics Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvy™ in Metastatic Urothelial Cancer
ZGNX: Zogenix, Inc 2020-09-10 08:00:10 Zogenix Announces Positive Top-Line Results from its Third Pivotal Phase 3 Clinical Trial (Study 3) of FINTEPLA® in Dravet Syndrome
SPRO: Spero Therapeutics, Inc. 2020-09-08 07:30:10 Spero Therapeutics Announces Positive Topline Results from its Phase 3 ADAPT-PO Clinical Trial of Oral Tebipenem HBr in Complicated Urinary Tract Infection and Acute Pyelonephritis
LLY: Eli Lilly and Company 2020-09-03 17:12:00 FDA approves additional doses of Trulicity® (dulaglutide) for the treatment of type 2 diabetes
RDHL: RedHill Biopharma Ltd. 2020-08-27 07:00:10 RedHill Biopharma Announces Positive Recommendation from Independent Committee to Continue U.S. Phase 2 COVID-19 Study, and Approval of COVID-19 Phase 2/3 Study in Italy
RGNX: REGENXBIO Inc. 2020-08-25 07:00:00 REGENXBIO Announces FDA Clearance of IND for Phase II Trial of RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery
IMMU: Immunomedics 2020-08-17 08:00:10 Immunomedics Announces FDA Approval of Samsung Biologics as Antibody Manufacturer for Trodelvy™
EBS: Emergent BioSolutions 2020-08-17 06:30:10 Emergent BioSolutions Announces FDA Approval of NARCAN® (naloxone HCl) Nasal Spray Shelf Life Extension to 36 Months
GWPH: GW Pharmaceuticals plc 2020-08-03 07:00:10 FDA Approves EPIDIOLEX® (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex
RDHL: RedHill Biopharma Ltd. 2020-07-31 07:00:10 RedHill Biopharma Announces FDA Clearance for Pivotal Phase 3 Study with RHB-204 for NTM Infections
RGLS: Regulus Therapeutics Inc. 2020-07-29 08:07:00 Regulus Therapeutics Announces FDA Orphan Drug Designation of RGLS4326 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
ABT: Abbott 2020-07-23 09:00:00 Abbott Receives FDA Approval for iOS-Compatible App Allowing People Living With Chronic Pain and Movement Disorders to Personalize Therapy Via Their Mobile Device
BSX: Boston Scientific Corporation 2020-07-21 16:24:00 Boston Scientific Receives FDA Approval for Next-Generation WATCHMAN FLX(TM) Left Atrial Appendage Closure Device
MGTX: MeiraGTx 2020-07-17 07:30:10 MeiraGTx Announces Positive Clinical Data Demonstrating Treatment with AAV-RPGR Investigational Gene Therapy Improves Vision in X-Linked Retinitis Pigmentosa Patients
OSMT: Osmotica Holdings US LLC 2020-07-09 06:50:10 Osmotica Pharmaceuticals plc Receives FDA Approval for Upneeq™ (oxymetazoline hydrochloride ophthalmic solution), 0.1% for Acquired Blepharoptosis (Droopy Eyelid) in Adults
IMMU: Immunomedics 2020-07-06 07:55:10 Immunomedics Announces Positive Results from Phase 3 ASCENT Study of TRODELVY™ in Previously-Treated Patients with Metastatic Triple-Negative Breast Cancer (mTNBC)
ABT: Abbott 2020-07-06 07:30:00 Abbott Receives FDA Approval for New Heart Rhythm Devices Featuring Bluetooth Connectivity and Continuous Remote Monitoring